The CDC states that, "Vaccines do not cause autism."  What evidence do they use to make that claim?  It goes on further to state that, "Some people have had concerns that ASD might be linked to the vaccines children receive, but studies have shown that there is no link between receiving vaccines and developing ASD." Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results <<< Back To Autism Vaccines Do Cause Autism >>> What Evidence Is Used To Conclude That Vaccines Do Not Cause Autism? The CDC website states that, "Vaccines do not cause autism." What evidence do they use to make that claim? It goes on further to state that, "Some people have had concerns that ASD might be linked to the vaccines children receive, but studies have shown that there is no link between receiving vaccines and developing ASD. The National Academy of Medicine, formerly known as Institute of Medicine, reviewed the safety of 8 vaccines to children and adults. The review found that with rare exceptions, these vaccines are very safe." I have linked the report from the IOM below. Using the search tool at the top of the report I did a search for the word "autism" which made it easy to find each instance autism is referenced in the report. Quickly I could see that the statement made by the CDC was deceptive and misleading . Again, the statement made by the CDC is that the IOM reviewed the safety of 8 vaccines . However, the IOM only looked at the evidence available for two vaccines in relationship to autism. The committee reviewed 22 studies to evaluate the risk of autism after the administration of MMR vaccine . Twelve studies were not considered due to passive surveillance data used in the studies. Six studies were not considered due to "very serious methodological limitations". Based on the FOUR remaining studies IOM determined "The evidence favors rejection of a causal relationship between MMR vaccine and autism ". The IOM also looked at a possible relationship to DTaP vaccines and autism. The committee reviewed ONE study to evaluate the risk and the study "was not considered in the weight of epidemiologic evidence because it provided data from a passive surveillance system and lacked an unvaccinated comparison population." The IOM concluded that, "The epidemiologic evidence is insufficient or absent to assess an association between diphtheria toxoid–, tetanus toxoid–, or acellular pertussis–containing vaccine and autism." Further misleading the CDC stated that according to this review, "with rare exceptions, these vaccines are very safe" . When in fact the IOM reviewed available literature for 158 of the most common injuries thought to be related to vaccination, in which they found the science “ convincingly supports a causal relationship ” for 14 of these serious injuries , including pneumonia, meningitis, hepatitis, MIBE (deadly brain inflammation a year after vaccination), febrile seizures, and anaphylaxis. The review found sufficient evidence to support “acceptance of a causal relationship” for 4 additional serious injuries . The IOM was unable to find sufficient evidence to conclude or deny the relationship of 135 other serious injuries. Institute of Medicine Report The second reference used by CDC to support their claim that VACCINES DO NOT CAUSE AUTISM is a CDC study published in 2013 that focused on the number of antigens received during the first two years of life. They concluded that, " increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines during the first 2 years of life was not related to the risk of developing an ASD. " This study in no way evaluates whether VACCINES cause autism. They don't look at how many vaccines each child received or which vaccines. Antigens have never thought to have been the issue in regards to autism and vaccines. Using this study on their website as proof that VACCINES do not cause autism is an insult to our intellegence. It also shows the CDCs overall lack of concern about children and families who are impacted by autism. If they wanted to prove that vaccines do not cause autism once and for all they would use the data they already have on millions of Americans and they would compare the rates of autism in the vaccinated against the rates in the un-vaccinated. They refuse to do this study, and have gone a step further by moving these records into a private company making it impossible for anyone else to access these records. Why? If they truly believe that VACCINES do not cause autism, why not do the study on vaccinated vs completely unvaccinated and end the debate once and for all??? I am not able to say the intentions of others but it certainly feels like they actually don't truly believe vaccines do not cause autism. It seems as though they care more about protecting the vaccine program and pharma profits, than they do about 1 in 44 kids who are having their chance at a normal life stolen from them. CDC Study on Autism & Antigens These are the only studies referenced on the CDC website in support of the claim that VACCINES DO NOT CAUSE AUTISM. They only reference TWO vaccines. One of which, DTaP, the report could neither acce pt OR deny a relationship between the vaccine and autism. THIS IS PATHETIC. But lets see what else they have to say. CDC goes on to state that, " vaccine ingredients do not cause autism". Lets look at the research they have used to support that statement. The first reference they use to support that claim is a 2004 scientific review by the IOM that concluded “the evidence favors rejection of a causal relationship between thimerosal–containing vaccines and autism.” In the review the IOM describes the five studies used to make that conclusion. 1. Hviid et al., 2003; Association between thimerosal-containing vaccine and autism Compared autism rates in those who received vaccines containing thimerosal with those that received thimerosal free vaccines. The mean age of diagnosis was 4.7 years old. However, the study included cases and controls as young as 1 years old . Meaning many of the subjects would later go on to receive an autism diagnosis . Also, instead of counting "persons" the authors counted "person-years of follow-up" meaning each age group was considered equially despite the fact that younger age groups were much less likely to have been diagnosed with autism as those in older groups. 2. Miller, 2004; Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association A retrospective cohort study completed using records from a database in the United Kingdom, where autism prevalence rates were compared for children receiving Thimerosal-containing DTaP and DT vaccines. Numerous statistical errors by correlating thimerosal exposure with year of birth. The authors of this study never released the raw data so that a valid single-variable analysis could be conducted to ascertain the probability of an association between Thimerosal exposure and the risk of autism. Also important is that the amount of thimerosal exposure in the UK was not comparable to that in the United States where children were getting larger exposures during younger periords of life. 3. Verstraeten et al., 2003 Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases A cohert analysis of records from the Vaccine Safety Datalink done by the CDC. This study had at least 5 phases. Results from the first phase showed that infants who were exposed to greater than 25𝜇g of Hg in vaccines and immunoglobulins at the age of one month were 7.6 times more likely to have autism diagnosis than those not exposed to any vaccine-derived organic Hg. The second phase they compared exposure from 3 months old instead of one month and found that children exposed to the maximum amount of organic Hg in infant vaccines (62.5𝜇g) were 2.48 times more likely to have autism diagnosis compared to those exposed to less than 37.5𝜇gof Hg in vaccines. The third phase used different inclusion/exclusion criteria stratisfying the data the relative risk of autism for children at three months of Thimerosal exposure dropped to 1.69. The fourth and fifth phase of the study used records from only two of the original HMOs and incorporated a third HMO, Harvard Pilgrim, into the analysis. The HMO used different diagnostic codes and in this study they included children from 0-3 years old even though the average age of autism diagnosis was 4.4 years. There was a lot of contraversy around the Verstraeten study. Emails obtained through FOIA requests show that Verstraeten was receiving pressure from the CDC to use methods to deny a casual relationship between thimerosal and autism. 4. Madsen et al., 2003; Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data CDC sponsored study that looked at whether discontinuing the use of thimerosal in vaccines in Denmark lead to a decreased rate of autism. The study examined the data from 1971 to 2000 and reported that rate of autism increased with the removal of Thimerosal from vaccines starting in 1992. However, autism rates only included those who were diagnosed in an inpatient setting from 1971-1994. In 1995 the inclusion of those diagnosed in an outpatient setting were added . The authors state that the outpatient setting had 4-6x that of the inpatient . In a previous publication the same authors using the same data reported 93.1% of children were treated only as outpatients. The inclusion of the outpatient population would explain why the numbers of autism cases continued to rise after phase out of thimerosal. Also inflating the numbers was the inclusion of a large clinic in the dataset starting in 1993. This clinic accounted for as many as 20% of a utism patients nationwide. Last, the diagnostic criteria for autism changed in 1994 resulting in an increased incidence by up to 25x what it was using previous diagnostic criteria . 5. Stehr-Green et al., 2003; Autis m and thimerosal-containing vaccines: lack of consistent evidence for an association Compared the prevalence/incidence of autism in California, Sweden, and Denmark with average exposures to thimerosal containing vaccines. This study used the same data from Denmark as the previous study. There was an artificial increase in autism rates by 20x following removal of thimerosal due to inclusion of outpatients starting in 1995 , the inclusion of a large clinic accounting for 20% of cases in 1993, change in diagnostic criteria in 1994. This study also used data from Sweden but looked at only inpatient cases of autism counting only a small portion of the actual cases of autism. Also, children in Sweden received a maximum 75 micrograms of Hg by age two. Children in California received up to 237.5 micrograms of Hg by 18 months. T his same report by the Institute of Medicine also states that, "Absent biomarkers, well-defined risk factors, or large effect sizes, THE COMMITTEE CANNOT RULE OUT , based on the epidemiological evidence, the possibility that vaccines contribute to autism in some small subset or very unusual circumstances." Your can veiw the IOM report H ER E . Read more about the flawed methods and manipulation of data- Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe Study Misses Link Between Thimerosal and Neurodevelopmental Disorders Letter to the Editor M. Geier , D. Geier; Published 2004; Medicine Summarized conflict of interest issues, manipulated data, and suppression of initial findings in the Verstraeten study. Read It Here "Since 2003, there have been nine CDC-funded or conducted studies that have found no link between thimerosal-containing vaccines and ASD. These studies also found no link between the measles, mumps, and rubella (MMR) vaccine and ASD in children." 1 Thimerosal exposure in early life and neuropsychological outcomes 7-10 years late Ֆ Barile JP, Kuperminc GP, Weintraub ES, Mink JW, Thompson WW Conflicts & Issues- Overmatching phenomena meant that cases and controls had very little difference in thimerosal exposure. More Info 2 Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, et al. Conflicts & Issues: Overmatching phenomena meant that cases and controls had very little difference in thimerosal exposure. Prenatal thimerosal effect was hidden by cherry-picking data. More Info 3 Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D’Elia L, et al. Conflicts & Issues: Study was completed using Italian vaccine schedule with much lower thimerosal exposure than U.S. schedule. No zero exposure control was use. More Info 4 Thimerosal-containing vaccines: evidence versus public apprehension DeStefano F. Destefano relied on flawed epidemiology studies from the U.K. and Denmark which follow different vaccination schedules compared to the U.S. Data from California show clear correlation between thimerosal uptake and autism incidence. More Info 5 Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosalfree or thimerosalcontaining vaccine McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. The definition of an adverse event was limited to site reactions and fever. No data were collected regarding any type of neurological outcome. More Info 6 Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years Thompson WW, Price C, Goodson B, Shay DK, Benson P, et al Overmatching phenomena meant that cases and controls had very little difference in thimerosal exposure. More Info 7 Safety of Thimerosalcontaining vaccines: a two-phased study of computerized health maintenance organization databases Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, et al Effects were diluted through five separate iterations of the study. Numerous exclusion criteria were erroneously applied and data cherry-picking was done to dilute statistically significant effects. More Info 8 Autism and thimerosalcontaining vaccines: lack of consistent evidence for an association Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Wrongfully dismissed autism rates in California as inclusion of milder ASD cases to obviate the rise in cases. More Info 9 Autism and thimerosalcontaining vaccines: lack of consistent evidence for an association Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D There was an artificial increase in autism rates by 20x following removal of thimerosal due to inclusion of outpatients starting in 1995 , the inclusion of a large clinic accounting for 20% of cases in 1993, change in diagnostic criteria in 1994 . More Info BACK TO TOP

A compilation of documents and articles showing conflicts of interest between pharmaceutical companies and the media, our educational institutions, and our government regulatory agencies. Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Conflicts of Interest A compilation of documents and articles showing conflicts of interest between pharmaceutical companies and the media, our educational institutions, and our government regulatory agencies Media In 2020 75% of TV ad spending came from Pharma. Click here to learn more. Research & Medical Institutions Pharmaceutical and medical device company contributions accounted for 28% of continuing medical education (CME) funding in 2017. Click here to learn more. Government & Regulatory Agencies Industry fees account for $2.9 billion of the FDA's $6.5 billion a year budget. Big Pharma Owns The Corporate Media, But Americans Are Waking Up And Fighting Back When you tune in to MSNBC, Fox News, or any of the other corporate media machines, you’re probably not going to hear much about the methods in which big pharma is taking advantage of consumers either through price gouging or medical mishaps. The reason for this is because talking about those stories creates a major conflict of interest for the people behind the scenes. Mike Papantonio discusses this with journalist and author Martha Rosenberg. DRUG INDUSTRY MONEY QUIETLY BACKS MEDIA VOICES AGAINST SHARING VACCINE PATENTS Doctors, economists, lawmakers, and civil society groups fighting the WTO waiver are funded by the pharmaceutical lobby Big Pharma Lobbied Social Media to Flag COVID ‘Misinformation,’ Latest ‘Twitter Files’ Reveal COVID-19 vaccine manufacturers, including Pfizer, BioNTech and Moderna, lobbied Twitter and other social media platforms to set moderation rules that would flag purported COVID-19-related “misinformation,” according to Lee Fang, who reported on the latest “Twitter files.” Yes, Fauci and Gates Do Have Ties to COVID-19 Vaccine Maker A USA Today headline falsely claiming Anthony Fauci and Bill Gates have “no ties” to Moderna is illustrative of a major problem with our media. Breaking: Landmark Lawsuit Slaps Legacy Media With Antitrust, First Amendment Claims for Censoring COVID-Related Content A lawsuit filed today by Robert F. Kennedy, Jr., and multiple other plaintiffs, alleges the Trusted News Initiative, a self-described “industry partnership” launched in March 2020 by several of the world’s largest news organizations, partnered with Big Tech firms to collectively censor online news. Conflicts of interest in health care journalism. Who’s watching the watchdogs? Ben Harder, a journalist with "US News & World Report," recently tweeted, “Pharma ads subsidize many health reporters’ salaries. Inside the Facebook Files: Emails Reveal the CDC's Role in Silencing COVID-19 Dissent Throughout the pandemic, the CDC was in constant contact with Facebook, vetting what users were allowed to say on the social media site. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study To examine the association between the presence of individual principal investigators’ financial ties to the manufacturer of the study drug and the trial’s outcomes after accounting for source of research funding. Stanford launches major effort to expedite vaccine discovery with $50 million grant The funding will establish the Stanford Human Systems Immunology Center, and will accelerate efforts to develop vaccines for the world's most deadly infectious diseases. Rockefeller Foundation, Nonprofits Spending Millions on Behavioral Psychology Research to ‘Nudge’ More People to Get COVID Vaccines The Rockefeller Foundation, the National Science Foundation and other nonprofits are pouring millions of dollars into a research initiative “to increase uptake of COVID-19 vaccines and other recommended public health measures by countering mis- and disinformation.” By Michael Nevradakis, Ph.D. Big Pharma Pays Universities for Most Medical Research in U.S. Today More than half of medical research funding in the U.S now comes from pharmaceutical companies, which exceeds funding of research by the National Institutes of Health. University of Washington To accelerate globally-informed and pregnancy-specific modeling to support drug development for maternal health Harvard Medical Students Rebel Against Pharma-Ties 200 Harvard Medical School STUDENTS are confronting the administration demanding an end to pharmaceutical industry influence in the classroom. Microsoft partners with the University of Washington to create the Tech Policy Lab 1 FDA receives 45% of its annual budget from industry More Info 2 The World Health Organization (WHO) gets half its budget from private sources, Pharma and its allied foundations More Info 3 CDC, is a vaccine company that owns 56 vaccine patents More Info CDC buys and distributes $4.6 billion in vaccines annually - Vaccines for Children program… over 40% of its total budget More Info 4 Pfizer Board – FDA Connection CDC Urged to Be Truthful About Its Corporate Financial Ties Public interest nonprofit organizations U.S. Right to Know and Public Citizen have petitioned the Centers for Disease Control and Prevention (CDC) to stop issuing false disclaimers that it “does not accept commercial support” and has “no financial interests or other relationships with the manufacturers of commercial products.”1 Gates Foundation Donations to WHO Nearly Match Those From U.S. Government President Donald Trump announced Friday that the U.S. would be ‘terminating’ its relationship with the World Health Organization. Trump’s FDA commissioner takes job at Moderna backer Stephen Hahn joins Flagship Pioneering, which launched Moderna a decade ago and made billions from its coronavirus vaccine Big Pharma’s Takeover of Modern Medicine Created a ‘Pandemic of Misinformed Doctors’ Cardiologist Dr. Aseem Malhotra shares data on the Big Pharma takeover of modern medicine and explains how it’s led to “a pandemic” of misinformed doctors who unwittingly harm and misinform their patients. 14 ACIP Members Who Voted to Jab Your Young Children — and Their Big Ties to Big Pharma On Nov. 2, members of the Centers for Disease Control and Prevention’s vaccine advisory committee voted 14–0 to recommend Pfizer’s pediatric COVID shot for children 5 –11 years old. Were their decisions driven by science and conscience — or their ties to drugmakers? Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns Science investigation of journal disclosures and pharmaceutical funding records shows potential influence on physician gatekeepers Thanks to Pfizer Vaccine, 3rd-Party Royalties to NIH Doubled to $127 Million in 2021 Adam Andrzejewski, founder of OpenTheBooks.com, told comedian and political commentator Russell Brand that 3,000 pages of documents produced by the National Institutes of Health were so heavily redacted that if “we didn't employ forensic data scientists these disclosures would have been absolutely worthless.” Committee that recommends vaccines for CDC schedule voting on COVID, other shots Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds Major pharmaceutical companies and trade groups helped fund the campaigns of more than 2,400 state legislators nationwide in the 2020 election. Bill & Melinda Gates Foundation Announces $750 Million Gift to Speed Delivery of Life-Saving Vaccines SEATTLE -- The Bill & Melinda Gates Foundation announced today a gift of $750 million over five years to help ensure that children in developing countries are immunized against major killer diseases in the new millennium Conflicts of Interest as a Health Policy Problem: Industry Ties and Bias in Drug Approval Home Page BACK TO TOP No Liability

Most of us have heard that vaccines are one of the greatest medical advancements of modern history.  It has been touted that vaccines have prevented more deaths in the last 50 years than any other advancement.  Where does this information come from? More importantly, is it true?  Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Many illnesses were on the decline prior to widespread vaccination Most of us have heard that vaccines are one of the greatest medical advancements of modern history. It has been touted that vaccines have prevented more deaths in the last 50 years than any other advancement. Where does this information come from? More importantly, is it true? The erad ication of Polio is often the first example people use when discussing how essential vaccines are. Although, in the package insert for the Inactivated Polio Vaccine it states, "Prior to the introduction of inactivated poliovirus vaccines in 1955, large outbreaks of 5 poliomyelitis occurred each year in the United States (US). The annual incidence of paralytic 6 disease of 11.4 cases/ 100,000 population declined to 0.5 cases by the time oral poliovirus vaccine 7 (OPV) was introduced in 1961" , Polio peaked in 1952 with 57,879 cases and 3,145 deaths. In 1954 the number of polio cases dropped to 38,476 with 1,368 deaths. In two years polio cases dropped by 40% and deaths were down 78%. The following year a vaccine became available. One question that comes to mind for me is the question of correlation vs causation. We hear it all of the time when someone is injured after vaccination, "Correlation doesn't equal causation". So why is it that when its an adverse event we cannot determine causation, but when it is eradication of a disease we can? Is it possible that there could have been other factors contributing to the eradication of wild type poliovirus? What about other diseases that have seen dramatic declines? Polio April 1955 IPV vaccine was adopted throughout the United States Polio types 2 and 3 have been eraticated. Type one is extremely rare. We now have more cases of vaccine derived poliovirus around the world than wild strain poliovirus. Most industrialized countries use the inactivated polio virus vaccines. Since they are not "live" vaccines they do not have the risk of Vaccine-associated Paralytic Polio. However, INACTIVATED POLIOVIRUS VACCINE DOES NOT STOP TRANSMISSION OF THE VIRUS Measles Vaccine was introduced in 1963 Approximately 400-500 people died from measles complications annually when the vaccine was introduced. That same year, 5,058 people died from asthma 32,465 died from diabetes mellitus 6,330 died from ulcer of the stomach 1,533 died from falling or projected objects There was a 98% reduction of Measles deaths PRIOR to the vaccine introduction Numbers from the United States Office of Vital Statistics View More Mortality Rates Drop Prior to Vaccinations A study published in 2000 in Pediatrics researchers from the Department of Population and Family Health Sciences, Johns Hopkins School of Public Health, The National Center for Health Statistics, and Centers for Disease Control and Prevention, concluded: “Thus vaccinations does not account for the impressive declines in mortality from infectious diseases seen in the first half of the twentieth century.” View More To see the listed side effects and the prelicensure safety studies check out- The Vaccine Inserts and Inadequate Safety Testing How do we explain the decline in diseases we never vaccinated against during the same time period? Contact Me Info@WhyIWon'tVax.com Submit Thanks for submitting! Home Page BACK TO TOP Vaccine Failure & Shedding

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results This is all a part of Big Pharma's "Sick Care Model." There are better ways to stay healthy We have become so used to taking pharmacuetical products anytime we have a pain or illness that we don't think twice about the long list of side effects these products can cause. We hear about how at the time vaccines were rolled out for covid, the data showed they were the best way out of the pandemic. But this isn't true. It never was true. Why were so many people willing to give up their careers before taking it? Because even then we knew there were other effective treatment options. Treatments with things that have been around for decades. These treatments have been given billions of times in the past and had great safety profiles. We knew even then that they were also showing to be highly effective at preventing death and hospitalizations from covid. So why take a vaccine that was rolled out in record time with very little safety data, if we have options we knew were safe and effective? It didn't make sense. Just like with the covid vaccine there are other pharmaceutical products that we take regularly that we are learning are not as safe as we were told. We are now being told that acetominophen can contribute to autism if taken while pregnant. However, a search of Pubmed shows the first study linking acetominophen to autism was done in 1996. 1996! They saw a link in 1996 and the general public did not hear about this information until 25 years later! You can find that study here. So should we continue to take vaccines when we are healthy in the hopes that they prevent us from getting sick? Ive already shown that many of these vaccines do not protect us as the side effects list the illness we are vaccinating against in many cases. You can see examples here . In cases where the vaccine does show its effective we see that while decreasing incidents of one illness we have skyrocketing numbers of chronic illnesses that go along with it. Examples of this can be found here. Do we need to prevent measles or chickenpox? Im going to give some examples of alternative ways of dealing with some of these illnesses. I will also start a section of alternative methods of treating other issues we overmedicate for like depression and methods for strengthening our immune systems and bodies as a whole. Feel free to comment below if you have anything to add. Other effective treatment options- Vaccines Welcome visitors to your site with a short, engaging introduction. Double click to edit and add your own text. Start Now BACK TO TOP

We have all been told at some point that it's important for everyone to get vaccinated in order to protect those who can't. It sounds good in theory but there are holes in this theory. Vaccine Failure, Shedding, Vaccine Derived Disease, Waning Immunity. Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results We have all been told at some point that it's important for everyone to get vaccinated in order to protect those who can't. We are given the image of a sick, immunocompromised child and told that this child will not be able to attend school with their peers, or go out into the community unless we all get vaccinated. Only then will we reach "heard immunity", protecting the child from illness by forming a sort of cocoon of protection around them. This idea sounds great in theory. I even fell for it after having my son. I dutifully went out and got my flu shot to protect my precious new baby boy. However, there are several holes in the theory. Vaccine Failure Shedding/ Vaccine Derived Disease Waning Immunity influenza vaccine propaganda by Jeremy R. Hammond Part One: Myths and Facts about Flu Shots Part Two: How the CDC Uses Fear and Deception to Sell More Flu Vaccines Part Three: How You’re Being Lied to about the Risks of Getting a Flu Vaccine Annually Vaccine Failure View More Featured The topic of vaccine failure has become increasingly popular over the last few years. We were told that vaccines would be the only way out of the pandemic. We were told that it was a "pandemic of the unvaccinated". We were told if we got vaccinated we would not get sick and that we would be protecting others from getting sick. I think it is safe to say that none of those things are true. It has a lot of people talking about what a failure these vaccines are. People rightfully feel as though they were lied to. But vaccine failure didn't start with the coivd vaccines. An article from Medical University Vienna describes vaccine failure "There are 2 major factors responsible for vaccine failures, the first is vaccine-related such as failures in vaccine attenuation, vaccination regimes or administration. The other is host-related, of which host genetics, immune status, age, health or nutritional status can be associated with primary or secondary vaccine failures. The first describes the inability to respond to primary vaccination, the latter is characterized by a loss of protection after initial effectiveness. " The article states that, "about 2-10% of healthy individuals fail to mount antibody levels to routine vaccines." Although it varies, some diseases such as measles need 95% vaccination rates in order to reach heard immunity. That means if every person that could get vaccinated did we likely still would not reach herd immunity. Immunized People Getting Whooping Cough June 12, 2014 By Joanne Faryon / Investigative Reporter, KPBS Staff Of the 621 people who contracted the illness, 85 percent had all their preventative shots — calling into question the efficacy of the vaccine. Read More The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines? January 5, 2012 Gregory A. Poland, MD, MACP, Editor-in-Chief, VACCINE and Robert M. Jacobson, MD, FAAP, Professor of Pediatrics Multiple studies demonstrate that 2–10% of those immunized with two doses of measles vaccine fail to develop protective antibody levels, and that immunity can wane over time and result in infection (so-called secondary vaccine failure) when the individual is exposed to measles. In an October 2011 outbreak in Canada, over 50% of the 98 individuals had received two doses of measles vaccine. Read More United States ex rel. Krahling v. Merck & Co. August 27, 2010 Nstural News Relators Krahlillg and WlochoWBki were OOlpioyed as virologists in the Merck lub that perlOOne3000 in DTwP vaccines), linked-epitope suppression occurs. Because of linked-epitope suppression, all children who were primed by DTaP vaccines will be more susceptible to pertussis throughout their lifetimes, and there is no easy way to decrease this increased lifetime susceptibility. Read More Vaccinated child had Maine’s first case of measles in 2 years, say health officials May 21, 2019 BY JOE LAWLOR STAFF WRITER “The child is vaccinated, did not have any serious complications, and is fully recovered from the disease,” Read More The Pink Book Centers for Disease Control -From 1985 through 1988, 68% of cases in school-aged children (age 5 to 19 years) occurred among those who had been appropriately vaccinated -In 2019, 13 outbreaks of measles were reported, accounting for 663 cases; six were associated with underimmunized close-knit communities -The original Edmonston B vaccine was withdrawn in 1975 because of a relatively high frequency of fever and rash in recipients. -Approximately 2% to 7% of children who receive only 1 dose of MMR vaccine fail to respond to it, i.e., they experience primary vaccine failure. MMR vaccine failure can occur because of passive antibody in the vaccine recipient, immaturity of the immune system, damaged vaccine, or other reasons. -Most adverse events reported following MMR vaccination (such as fever and rash) are attributable to the measles component. - “During the 1989 -1991 measles resurgence, incidence rates for infants were more than twice as high as those in any other age group. The mothers of many infants who developed measles were young, and their measles immunity was most often due to vaccination rather than infection with wild virus. As a result, a smaller amount of antibody was transferred across the placenta to the fetus, compared with antibody transfer from mothers who had higher antibody titers resulting from wild-virus infection. The lower quantity of antibody [in the vaccine] resulted in immunity that waned more rapidly, making infants susceptible at a younger age than in the past.” Read More The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis [version 1; peer review: 2 approved] August 25, 2017 Christopher J. Gill Pejman Rohani, Donald M Thea In conclusion, the preponderance of available evidence now suggests that the list of plausible explanations for the resurgence of pertussis in the aP vaccination era goes beyond the “poor persistence” and “waning efficacy” of these vaccines to include an additional and likely pivotal factor: “lack of sterilizing mucosal immunity”. the current burden of disease is not well explained by the disease that is observed but implies asymptomatic chains of transmission; aP vaccination, or passively acquired antibodies resulting from aP vaccination, prevents symptomatic disease in animals but does not block infections; transmission readily occurs between asymptomatic aP-vaccinated but infected animals to uninfected animals in close physical proximity; Read More Fifty-one percent of cases of patients in a 1998/1999 mumps outbreak had at least one MMR vaccination, indicating their effectiveness may be overestimated. July 1, 2005 Richard Harling, Joanne M White, Mary E Ramsay, Karen F Macsween, Corry van den Bosch The observed effectiveness of any MMR vaccination adjusted for age, sex and general practice was 69%. - Two doses of vaccine were more effective (88%) than a single dose (64%). Read More The Navy's fighting to get a rare viral mumps outbreak under control after it stranded a US warship at sea March 29, 2019 Business INSIDER Ryan Pickrell -27 sailors and Marines aboard the dock landing ship USS Fort McHenry have been diagnosed with parotitis, which the Navy described in a statement earlier this month as a "viral infection which has symptoms similar to mumps." -Viral parotitis is an infection of the saliva glands on either side of the face that's typically caused by the mumps. -“The Navy’s position is that vaccines are effective at reducing the incidence and severity of vaccine-preventable diseases,” BUMED told BI. Unfortunately, “the mumps portion of the measles, mumps, and rubella (MMR) vaccine is the least effective of the three components, providing 88% effectiveness after completion of the two dose series” Read More Load More Shedding/Vaccine Derived Disease From MerckVaccines.com Re: Varivax (Chickenpox) Vaccine Due to the concern for transmission of vaccine virus, vaccine recipients should attempt to avoid, whenever possible, close association with susceptible high-risk individuals for up to 6 weeks following vaccination . .Vaccine recipients should avoid close contact with high-risk individuals susceptible to varicella due to possible risk of transmission . Varicella vaccine virus transmission may occur between vaccine recipients and contacts susceptible to varicella including healthy individuals. Other reported adverse reactions in all age groups include: varicella-like rash (injection site) and varicella-like rash (generalized). VARIVAX may establish latency of varicella zoster virus in immunocompetent individuals, with the potential for later development of herpes zoster. From Merck.com M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live) Measles inclusion body encephalitis (MIBE), pneumonitis, and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine. In this population, disseminated mumps and rubella vaccine virus infection have also been reported. The following adverse reactions include those identified during clinical trials or reported during post-approval use of M-M-R II vaccine or its individual components. atypical measles measles inclusion body encephalitis (MIBE) measles-like rash RotaTeq- Rotavirus Vaccine "The spread of vaccine virus to non-vaccinated contacts has been reporte d. Tell your doctor if you have someone in your household who has a weak immune system, cancer, or is taking medications that can weaken the immune system so that your doctor can provide further advice." FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) Intranasal Spray From The Insert Shedding Studies Shedding of vaccine viruses within 28 days of vaccination with FluMist was evaluated in (1) multi-center Study MI-CP129 which enrolled healthy individuals 6 through 59 months of age (N = 200); and (2) multi-center Study FM026 which enrolled healthy individuals 5 through 49 years of age (N = 344). In each study, nasal secretions were obtained daily for the first 7 days and every other day through either Day 25 and on Day 28 or through Day 28. In Study MI-CP129, individuals with a positive shedding sample at Day 25 or Day 28 were to have additional shedding samples collected every 7 days until culture negative on 2 consecutive samples. Results of these studies are presented in Table 5 Measles outbreak in a fully immunized secondary-school population T L Gustafson, A W Lievens, P A Brunell, R G Moellenberg, C M Buttery, L M Sehulster Serum samples from 1806 students at two secondary schools were obtained eight days after the onset of the first case. Only 4.1 percent of these students (74 of 1806) lacked detectable antibody to measles according to enzyme-linked immunosorbent assay, and more than 99 percent had records of vaccination with live measles vaccine. We conclude that outbreaks of measles can occur in secondary schools, even when more than 99 percent of the students have been vaccinated and more than 95 percent are immune. March 26, 1987 Read More Spotlight on measles 2010: Excretion of vaccine strain measles virus in urine and pharyngeal secretions of a child with vaccine associated febrile rash illness, Croatia, March 2010 separator commenting unavailable B Kaic1 , I Gjenero-Margan1 , B Aleraj1 , T Vilibić-Čavlek2 , M Santak3 , A Cvitković4 , T Nemeth-Blazic1 , I Ivic Hofman4 We describe excretion of measles vaccine strain Schwarz in a child who developed a febrile rash illness eight days after primary immunisation against measles, mumps and rubella. Throat swabs and urine specimens were collected on the fifth and sixth day of illness, respectively. Genotyping demonstrated measles vaccine strain Schwarz (genotype A). If measles and rubella were not under enhanced surveillance in Croatia, the case would have been either misreported as rubella or not recognised at all June 4, 2010 Read More Shedding of Infectious SARS-CoV-2 Despite Vaccination Kasen K. Riemersma, DVM, PhD1 ; Brittany E. Grogan, MPH2 ; Amanda Kita-Yarbro, MPH2 ; Peter J. Halfmann, PhD1 ; Hannah E. Segaloff, PhD3 ; Anna Kocharian, MS4 ; Kelsey R. Florek, MPH, PhD5 ; Ryan Westergaard, MD, PhD6 ; Allen Bateman, PhD5 ; Gunnar E. Jeppson, BS7 ; Yoshihiro Kawaoka, DVM, PhD1 ; David H. O’Connor, PhD8 ^; Thomas C. Friedrich, PhD1 ^; Katarina M. Grande, MPH2 ^ these results indicate that even asymptomatic, fully vaccinated people might shed infectious virus. August 21, 2021 Read More Oral polio vaccinees can continue to shed for at least 13 weeks. Stephanie B Troy, Leticia Ferreyra-Reyes, Chunhong Huang, Nadim Mahmud, Yu-Jin Lee, Sergio Canizales-Quintero, Harry Flaster, Renata Báez-Saldaña, Lourdes García-García, Yvonne Maldonado During replication, oral polio vaccine (OPV) can revert to neurovirulence and cause paralytic poliomyelitis. In individual vaccinees, it can acquire specific revertant point mutations, leading to vaccine-associated paralytic poliomyelitis (VAPP). With longer replication, OPV can mutate into vaccine-derived poliovirus (VDPV), which causes poliomyelitis outbreaks similar to those caused by wild poliovirus. Our real-time PCR assay was able to detect small amounts of OPV in both stool and sewage and to distinguish nonrevertant and revertant serotypes and demonstrated that OPV continues to circulate at least 13 weeks after a NID in a Mexican population routinely immunized with IPV. March 16, 2011 Read More Differentiating the wild from the attenuated during a measles outbreak Lindsay Nestibo, BN RN, Bonita E Lee, MD FRCPC MSC (Epi), Kevin Fonseca, PhD D(ABMM), Jennifer Beirnes, Marcia M Johnson, MD MHSc FRCPC, Christopher A Sikora, MD MSc MPH CCFP FRCPC In the midst of a local measles outbreak, a recently immunized child was investigated for a new-onset measles-type rash. Nucleic acid testing identified that a vaccine-type measles virus was being shed in the urine. April 1, 2012 Read More Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013 M Murti1 , M Krajden2 , M Petric2 , J Hiebert3 , F Hemming1 , B Hefford4 , M Bigham1 , P Van Buynder1 We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster. November 15, 2013 Read More Circulating vaccine-derived poliovirus type 2 – Global update The World Health Organization In 2020, 959 human cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) and 411 cVDPV2-positive environmental samples were reported globally from 27 countries March 26, 2021 Read More Of the 13,749 acute flaccid paralysis cases investigated, 58.9% received at least three doses of oral polio vaccine. Hugo Kavunga Membo, Aaron Mweene, Serge Alain Sadeuh-Mba, Justin Masumu, Riziki Yogolelo, Norbert Ngendabanyikwa, Eddy Sokolua, Fred Sagamiko, Edgar Simulundu, Steve Ahuka, Jean Jacques Muyembe Of the 13,749 AFP cases investigated, 58.9% received at least three doses of oral polio vaccine (OPV), 7.3% never received OPV, while the status of 18.3% was unknown. June 22, 2016 Read More Detection of measles vaccine in the throat of a vaccinated child Florence Morfin a, Anne Beguin b 1, Bruno Lina a, Danielle Thouvenot a We report here the case of a child presenting with fever 8 days after vaccination with a measles–mumps–rubella vaccine. Measles virus was isolated in a throat swab taken 4 days after fever onset. This virus was then further genetically characterised as a vaccine-type virus. February 22, 2002 Read More Post-vaccine measles in a child with concomitant influenza, Sicily, Italy, March 2015 F Tramuto1,2 , P Dones3 , C D’Angelo4 , N Casuccio4 , F Vitale1,2 We describe the occurrence of measles in an 18 month-old patient in Sicily, Italy, in March 2015, who received the first dose of a measles-containing vaccine seven days before onset of prodromal symptoms. Measles virus infection was confirmed by PCR and detection of specific immunoglobulin; viral genotyping permitted the confirmation of a vaccine-associated illness. May 7, 2015 Read More In 2011, there were an extra 47,500 new cases of non-polio acute flaccid paralysis (NPAFP); Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received. Neetu Vashisht, Jacob Puliyel In 2011, there were an extra 47,500 new cases of NPAFP. Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received. Though this data was collected within the polio surveillance system, it was not investigate April 1, 2012 Read More At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology. L H de Oliveira, C J Struchiner At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology. Among individuals who had received oral polio vaccine (OPV) from 4 to 40 days before the onset of paralysis, we found a relative risk of 8.88 (95% CI: 4.37-18.03) for VAPP as compared with persons who had not been vaccinated during the same time interval. A major share of VAPP cases were related to children affected by prodromes (fever and gastrointestinal signs and/or symptoms), isolation of vaccine poliovirus type 2, paralysis of the lower limbs, and a mean age of 1 year. April 1, 2000 Read More Load More Waning Immunity "There are insufficient data to assess the rate of protection of VARIVAX against the serious complications of chickenpox in adults (eg, encephalitis, hepatitis, pneumonia), and during pregnancy (congenital varicella syndrome)." "The duration of protection from varicella infection after vaccination with VARIVAX is unknown." merckvaccines.com/varivax/ Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children " long-term annual vaccination using inactivated vaccines may hamper the induction of cross-reactive CD8+ T cell responses by natural infections and thus may affect the induction of heterosubtypic immunity. This may render young childr en who have not previously been infected with an influenza virus more susceptible to infection with a pandemic influenza virus of a novel subtype ." Journal of Virology Whooping Cough Outbreak: How Effective Is the Vaccine? Widespread pertussis vaccine use at a Florida preschool failed to keep the disease away from about three dozen students, staff and family members By Cari Nierenberg , LiveScience on January 14, 2016 SCIENTIFIC AMERICAN Waning Tdap Effectiveness in Adolescents Klein NP, Bartlett J, Fireman B, Baxter R. Waning Tdap Effectiveness in Adolescents. Pediatrics. 2016 Mar;137(3):e20153326. doi: 10.1542/peds.2015-3326. Epub 2016 Feb 5. PMID: 26908667. Routine Tdap did not prevent pertussis outbreaks. Among adolescents who have only received DTaP vaccines in childhood, Tdap provided moderate protection against pertussis during the first year and then waned rapidly so that litle protection remained 2-3 years after vaccination.. https://pubmed.ncbi.nlm.nih.gov/26908667/ Home Page BACK TO TOP Autism

By removing liability through NVICP & PREP Act, then making products mandatory we have created a very lucrative business model for vaccine makers.  There is no longer an incentive for manufacturers to invest in making their products safe. Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results There Is No Liability For Injuries. With most products on the market consumers have the ability to bring litigation against the manufacturer if that product causes injuries. If your seatbelt is faulty and you are injured in a crash because of it, you can sue the car manufacturer for those injuries This is true for any of the products that we as consumers buy and use. Despite Bidens claim that gun manufacturers are the only industry in America that can't be sued , even they can and have been sued. According to an article in Forbes, "Plaintiffs do not need to prove that the defendant acted negligently or intentionally in product liability cases. That’s because a legal doctrine called “strict liability” applies in these types of claims. Under strict liability rules, plaintiffs can prove their case and prevail in court if they simply show that the problem with the product was the direct cause of unexpected harm." In the medical industry you can sue if you are injured due to physician negligence, or faulty medical devices . For example, thousands of lawsuits have been filed against manufacturers who made metal on metal hip replacements . More than $7 Billion has been paid out in settlements for these lawsuits. If you are injured due to taking a medication you can sue the pharmacuetical companies. Currently there are over 13,000 open lawsuits in New Jersey for those injured by proton pump inhibiters such as prilosec. Claims allege that companies failed to warn consumers about the drugs potential risks of kidney failure, kidney disease , and other injuries . Having the ability to file a lawsuit for injuries is important for a number of reasons. The thing that usually comes to mind for people is the financial compensation that those who are injured may need for medical bills, missed work, and compensation for pain and suffering. Another important part of litigation is that it creates a system in which manufacturers must search for and produce products that are safe for their own survival. It gives them an incentive to invest into the safety of their products or face litigation that could potentially bankrupt the company. The incentive to invest money into safety is reduced greatly when a company understands that they do not have to be accountable for damages. However, a company may still consider safety testing important if they want consumers to purchase their products. With vaccines, consumers are required to take this product to enter schools and daycares. Often they must continue to get vaccines as adults to work in certain career fields. By removing liability and then making the products mandatory for every person in the country we have created an extremely lucrative business model for manufacturers. There is no longer an incentive for manufacturers to invest in making their products safe. Why Is There No Liability For Vaccine Manufactureres? The National Vaccine Injury Compensation Program (NVICP) The National Vaccine Injury Compensation Program (NVICP) was establised by congress in 1986 as a no-fault alternative to the traditional legal system. Prior to this there were concerns that potential liablity for injuries caused by vaccines threatened the vaccination program and acted as a deterrant to vaccine manufacturing. The United States was facing a vaccine shortage that was thought to threaten public health. These concerns led to the establishment of The Committee on Public-Private Sector Relations in Vaccine Innovation by the Institute of Medicine in 1983. The committee was asked to do a comprehensive study of vaccine research and development, production and supply, and utilization. Their report and reccommendations were published in 1985. You can find that full report HERE. In their report they state that, "A manufacturer is not liable for harm caused by a nondefective product due to its inherent or unavoidable dangerousness . Thus, if a properly manufactured vaccine will cause harmful side effects in some portion of the recipient population, the manufacturer of the vaccine is not liable for those side effects." They go on to state that some products are " Unavoidably unsafe products. There are some products which, in the present state of human knowledge, are quite incapable of being made safe for their intended and ordinary use. " The report notes that those injured by vaccines should recieve compensation and that the traditional legal system can be complex, expensive and time consuming. Therefore, the committee recommends the development of a compensation program where claims should be processed without regard to "fault". They recommend the establishment of a schedule of events for which scientific evidence indicates a plausible association with vaccination. The goal of the NVICP was to encourage investment in vaccine development and manufacturing and to compensate those who are injured in a timely mannor. The program seems to have been effective at encouraging vaccine development. With the threat of liability off the table the vaccination program has exploded. In 1986 children recieved 12 doses of 8 vaccines. In 2023 we are up to 58 doses of 18 vaccines from birth-18 years, plus 2 injections for 4 vaccines in-utero. This chart from Children's Health Defense shows vaccine schedules from 1986 compared to 2019. We have since added 3 doses of Covid-19 vaccinations to the schedule. However, the program has not been as successful when it comes to making sure those who are injured are compensated for their injuries. The program has a table of covered vaccines and injuries that will qualify for compensation if they fall within a certain time frame of being vaccinated. For injuries that are not listed on the table the burden of proof lies with the petitioner. The program also has a very strict time limit of 3 years from the time of injury to file a claim. Since 1988 there have been 25,961 claims filed and 9,664 of those were compensated. Considering there have been 2,439,553 reports of injury to VAERS following vaccination , and that a report by Harvard Pilgrim Health noted, "fewer than 1% of vaccine adverse events are reported" to VAERS , there seems to be a very small number of individuals with injuries actually filing a claim with the NVICP. (See What Is VAERS?) The program has also not been a timely process for petitioners. A report from the U.S. Government Accountability Office looked at the data for claims filed between 1999-2014 and found that most claims took multiple years to process. View More "Every year, a number of children are seriously injured by adverse reactions to vaccines. When such a tragedy befalls a family, they are faced with devastating emotional and financial consequences. As the devastation of adverse reactions can lead to paralysis, permanent disability and death, families without adequate insurance can face enormous expenses, including residential care, therapy, medical equipment, and drugs." -COMMITTEE ON GOVERNMENT REFORM, SIXTH REPORT Public Readiness and Emergency Preparedness Act (PREPA) The Public Readiness and Emergency Preparedness Act (Prep Act or PREPA) was enacted by Congress in 2005. Health & Human Services describes the PREP Act on their website , "The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of the Department of Health and Human Services (Secretary) to issue a PREP Act declaration. The declaration provides immunity from liability (except for willful misconduct) for claims: of loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions determined by the Secretary to constitute a present, or credible risk of a future public health emergency to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures A PREP Act declaration is specifically for the purpose of providing immunity from liability, and is different from, and not dependent on, other emergency declarations." Immunity means that courts must dismiss claims brought against any entity or individual covered by the PREP Act. Claims that courts must dismiss include claims for any loss that is related to any stage of design, development, testing, manufacture, labeling, distribution, formulation, labeling, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing or use of a countermeasure recommended in a Declaration. This includes, but is not limited to, claims for: death; physical, mental, or emotional injury, illness, disability, or condition or fear of any such injury, illness, disability, or condition; any need for medical monitoring; or property damage or loss, including business interruption loss. The only exception is for claims of willful misconduct. From the U.S. Department of Health & Human Services A Declaration may provide liability immunity for covered persons. Covered persons may include, at the Secretary’s discretion: Manufacturers of countermeasures; Distributors of countermeasures; Program planners , i.e., individuals and entities involved in planning, administering, or supervising programs for distribution of a countermeasure (e.g., State or local governments, Indian tribes, or private sector employers or community groups that establish requirements or provide guidance, technical or scientific advice or assistance, or provide a facility); Qualified persons, i.e., persons who prescribe, administer, or dispense countermeasures such as healthcare and other providers or other categories of persons named in a Declaration, e.g., volunteers; Officials, agents, and employees of any of these entities or persons; and The United States. A “covered countermeasure” may be: A qualified pandemic or epidemic product ; A security countermeasure ; An unapproved drug , biological product , or device used under an Emergency Use Authorization (EUA) issued by FDA; An approved drug , biological product , or device used pursuant to Federal law in conditions that are in consistent with its approval ; or An unapproved drug , biological product , or device , or an approved drug, biological product , or device intended for an unapproved use, that is intended for emergency use and shipped and held by a government agency or someone working on that agency’s behalf for use only when that use is authorized. The PREP Act states that those who are seriously injured, described as an injury that warranted hospitalization (whether or not the person was actually hospitalized) or that led to a significant loss of function or disability, by a declared countermeasure may file a claim with the Countermeasures Injury Compensation Program (CICP) within one year of the injury. " If no funds have been appropriated to the compensation program, or the Secretary does not make a final determination on the individual’s request within 240 days, or the individual decides not to accept the compensation, the injured individual or his representative may pursue a tort claim in the United States District Court for the District of Columbia, but only if the claim involves willful misconduct and meets the other requirements for suit under the PREP Act . If the individual accepts compensation from the CICP, or if there is no willful misconduct, the individual does not have a tort claim that can be filed in a United States Federal or a State court. Any award is reduced by public or private insurance or worker’s compensation available to the injured individual. Awards for non-economic damages, such as pain, suffering, physical impairment, mental anguish, and loss of consortium are also limited ." CICP may compensate for medical expenses, lost employment income, and survivors benefits. However, it is a last resort and will only pay for expenses that are not compensated by other means such as health insurance and workmans comp. Unlike the NVICP, the CICP will not cover lawyer fees. Since 2010 there have been only 30 claims compensated through the CICP CICP Data for Fiscal Years 2010 – 2023 (As of March 1, 2023) Total CICP Claims Filed: 11,765 Pending Review or In Review: 10,629 Decisions: 1,136 Claims Found Eligible for Compensation: 61 Claims Compensated: 30 Claims Pending Benefits Determination: 21 Claims with No Eligible Reported Expenses: 10 Denied: 1,075 Requested Medical Records Not Submitted: 182 Standard of Proof Not Met and/or Covered Injury Not Sustained: 324 Missed Filing Deadline: 248 Not CICP Covered Product/Not Specified: 321 There Is Also No Mandated Reporting For Injuries In a research project conducted by Harvard Pilgrem Health over a span of three years and funded by a grant from Health and Human Services, it was noted that "fewer than 1% of vaccine adverse events are reported. " The team at Harvard Pilgrem Health developed a way to electronically monitor medical records and notify physticians of possible adverse events following reciept of vaccinations. This would prompt the physician to review the records and submit the event to the VAERS system, along with any optional notes or to note in the record reasons for not submitting to VAERS. The team concludes that after three years of collecting data and development of the automated system they were unable to move forward with implementing the program, "Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation." More information can be found HERE One report describes VAERS as a spontaneous surveillance system and explains, " Spontaneous surveillance means that no active effort is made to search for, identify and collect information, but rather information is passively received from those who choose to voluntarily report their experience. Therefore, VAERS relies on the intuition and experience of healthcare professionals in particular, but likewise for patients, parents and caregivers, to recognize and report unusual or unexpected events following vaccination or suspected vaccine safety problems. " This same report notes that, "During 2011-2014, VAERS averaged around 30,000 U.S. reports annually, with 7% classified as serious." If VAERS is only representiong 1% of adverse events that would mean the number of actual adverse events during that 3 year period was closer to 3,000,000 annually with about 210,000 a year being serious. Some might say that is a small number compared to the number of vaccine doses administered each year, but when its your child who is injured the number isn't small at all. Another important point to consider is "Vaccines are generally given to healthy individuals to prevent disease, whereas drugs are primarily given for treatment of illness. Sick patients, or parents of sick children, might be more willing to accept safety risks of drugs used to treat illnesses compared to vaccines used to prevent possible future illnesses." 210,000 serious injuries a year starts to seem like a lot when you consider many of these injuries happened in perfectly healthy children. Looking back on our own personal experience my son was seen in urgent care 3 times in the 30 days following his first round of vaccines. None of these visits were reported to VAERS. Not one of the doctors, nurses, or other medical professionals (such as those at the WIC office or our public healt h nurse who came out to visit us weekly) ever mentioned that vaccines could have been related to the issues we were having. Sadly, I was unaware that it was even possible for vaccines to cause these problems. Then dealing with a sick baby who would not eat or sleep and screamed non-stop, I was sleep deprived and stressed out and not able to see clearly the connection that is so obvious to me when looking back. Whether is was caused by the vaccine or not those urgent care visits should have been reported to VAERS so that it could be used to look for signals. If there are a high number of urgent care visits with similar complaints following the same vaccinations that would raise a flag for our regulatory agencies to look at it further. If things are not reported then they can't find possible connections. Home Page BACK TO TOP The Vaccine Inserts

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results BACK TO INGREDIENTS Polysorbate 80 Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner Holder MK, Peters NV, Whylings J, Fields CT, Gewirtz AT, Chassaing B, de Vries GJ. Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner. Sci Rep. 2019 Jan 17;9(1):172. doi: 10.1038/s41598-018-36890-3. PMID: 30655577; PMCID: PMC6336787. Dietary emulsifiers carboxylmethylcellulose (CMC) and polysorbate 80 (P80) alter the composition of the intestinal microbiota and induce chronic low-grade inflammation, ultimately leading to metabolic dysregulations in mice. Importantly, emulsifier treatment altered anxiety-like behaviors in males and reduced social behavior in females. It also changed expression of neuropeptides implicated in the modulation of feeding as well as social and anxiety-related behaviors. Read More Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes Tatsuishi T, Oyama Y, Iwase K, Yamaguchi JY, Kobayashi M, Nishimura Y, Kanada A, Hirama S. Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes. Toxicology. 2005 Feb 1;207(1):7-14. doi: 10.1016/j.tox.2004.07.020. PMID: 15590117. Polysorbate 80 at clinically-relevant concentrations increases the cytotoxicity of hydrogen peroxide under the in vitro condition. Result suggests that polysorbate 80 may increase the susceptibility of cells to oxidative stress. Read More Dual effects of Tween 80 on protein stability Wang W, Wang YJ, Wang DQ. Dual effects of Tween 80 on protein stability. Int J Pharm. 2008 Jan 22;347(1-2):31-8. doi: 10.1016/j.ijpharm.2007.06.042. Epub 2007 Jul 3. PMID: 17692480. Tween 80 increased the rate of oxidation in general but also altered the temperature-dependency of IL-2 mutein oxidation. Read More Polysorbate 80-induced leaky gut impairs skeletal muscle metabolism in mice Nishimura S, Aoi W, Kodani H, Kobayashi Y, Wada S, Kuwahata M, Higashi A. results suggest that daily PS80 intake induces intestinal permeability, leading to glucose intolerance and mitochondrial dysfunction in the skeletal muscle. Read More Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma Viennois E, Chassaing B. Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma. Int J Mol Sci. 2021 Mar 5;22(5):2602. doi: 10.3390/ijms22052602. PMID: 33807577; PMCID: PMC7961571. Overall, our findings further support the hypothesis that emulsifier consumption may be a new modifiable risk factor for colorectal cancer (CRC) and that alterations in host-microbiota interactions can favor gastrointestinal carcinogenesis in individuals with a genetical predisposition to such disorders. Read More Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier Zhao YM, Xia AX, Wei YH, Ruan YP, Li FZ. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier]. Yao Xue Xue Bao. 2010 Oct;45(10):1312-6. Chinese. PMID: 21348312. polysorbate-80 modified neurotoxin nanoparticles can transport across the BBB Read More Dietary emulsifier polysorbate-80-induced small-intestinal vulnerability to indomethacin-induced lesions via dysbiosis Furuhashi H, Higashiyama M, Okada Y, Kurihara C, Wada A, Horiuchi K, Hanawa Y, Mizoguchi A, Nishii S, Inaba K, Sugihara N, Watanabe C, Komoto S, Tomita K, Miura S, Hokari R. Polysorbate-80 enhances the vulnerability of the small intestine to indomethacin-induced injury by inducing ileal dysbiosis. Direct enhancement of the motility of specific flagellated microbiota by P80 might be related to dysbiosis and intestinal injury. Read More Flow-cytometric analysis on adverse effects of polysorbate 80 in rat thymocytes Hirama S, Tatsuishi T, Iwase K, Nakao H, Umebayashi C, Nishizaki Y, Kobayashi M, Ishida S, Okano Y, Oyama Y. Polysorbate 80 increases membrane permeability and decreased glutathione content. Read More Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res. 2017 Jan 1;77(1):27-40. doi: 10.1158/0008-5472.CAN-16-1359. Epub 2016 Nov 7. PMID: 27821485; PMCID: PMC5214513. Here, we demonstrate in a preclinical model of colitis-induced colorectal cancer that regular consumption of dietary emulsifiers, carboxymethylcellulose or polysorbate-80, exacerbated tumor development. Enhanced tumor development was associated with an altered microbiota metagenome characterized by elevated levels of lipopolysaccharide and flagellin Read More Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles Ren T, Xu N, Cao C, Yuan W, Yu X, Chen J, Ren J. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles. J Biomater Sci Polym Ed. 2009;20(10):1369-80. doi: 10.1163/092050609X12457418779185. PMID: 19622277. The prepared nanoparticles were spherical with homogeneous distribution. Drug concentration in mice brain was greatly enhanced, which indicated that the coated nanoparticles could get across the BBB Read More Macromolecules in polysorbate 80 for injection: an important cause of anaphylactoid reactions Li Y, Duan J, Xia H, Li Y, Shu B, Duan W. macromolecular impurities may cause strong anaphylactoid reactions, passive cutaneous anaphylactoid (PCA) reactions, pulmonary capillary permeability, vasodilation, and severe hemolysis Read More Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. relatively low concentrations of two commonly used emulsifiers, namely carboxymethylcellulose and polysorbate-80, induced low-grade inflammation and obesity/metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder. Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and increased pro-inflammatory potential. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Return to Ingredients Aluminum Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008. Epub 2011 Aug 23. PMID: 22099159. Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades Read More Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure Seneff, S.; Davidson, R.M.; Liu, J. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure. Entropy 2012, 14, 2227-2253. https://doi.org/10.3390/e14112227 In this paper, we have presented some analyses of the VAERS database which strongly suggest that the aluminum in vaccines is toxic to vulnerable children. While we have not shown that aluminum is directly causative in autism, the compelling evidence available from the literature on the toxicity of aluminum, combined with the evidence we present for severe adverse reactions occurring much more frequently following administration of aluminum-containing vaccines as compared to non-aluminum-containing vaccines, suggests that neuronal damage due to aluminum penetration into the nervous system may be a significant factor in autism. Read More Experimental Epilepsy in the Monkey Following Multiple Intracerebral Injections of Alumina Cream Joseph G. Chusid, Lenore M. Kopeloff, Ph.D. and Nicholas Kopeloff, Ph.D. The Bulletin, 1953. Aluminum caused tics and grand mal seizures in monkeys. Read More Macrophagic myofasciitis lesions assess long-term persistence of vaccine derived aluminum hydroxide in muscle R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P.A. Dreyfus. Brain, 2001, 124, 1821-1831. French scientists tie aluminum adjuvant in vaccine to macrophagic myofasciitis. Read More Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction Maryline Couette, Marie-Françoise Boisse, Patrick Maison, Pierre Brugieres, Pierre Cesaro, Xavier Chevalier, Romain K. Gherardi, Anne-Catherine Bachoud-Levi, François-Jérôme Authier. Journal of Inorganic Biochemistry, 2009. French scientists report aluminum from vaccines causes chronic cognitive dysfunction. Read More Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity Shaw C, Tomljenovic L. Immunologic Research. 2013;56:304–316. Canadian researchers: aluminum in vaccines can cause both autoimmunity and neurological damage. Read More Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Journal of Autoimmunity. 2013;47:1-16. Israeli and Italian researchers demonstrate that exposure to aluminum in vaccines can lead to autoimmune and brain dysfunction. Read More Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods. Fanni D, et al. World Journal of Pediatrics, 2014 May; 10(2):101-7. Newborns have been overexposed to aluminum. Read More Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity Tanveer Singh and Rajesh Kumar Goel. NeuroToxicology, 49 (2015) 1–7. Chronic aluminium administration resulted in significant motor incoordination and memory deficits, which were also endorsed biochemically as there was increased oxidative stress as well as elevated aluminium levels in the brain. Read More Assessment of hair aluminum, lead, and mercury in a sample of autistic Egyptian children: Environmental risk factors of heavy metals in autism El Baz Mohamed F, Zaky EA, Bassuoni EI-Sayed A, et al. Behavioural Neurology. 2015, Article ID 545674. Autistic children accumulate metals at a much higher level than children who do not have a diagnosis of autism. Read More On vaccine’s adjuvants and autoimmunity: Current evidence and future perspectives Pellegrino P, Clementi E, Radice S. Autoimmunity Reviews. 2015;14(10):880-888. The specific mechanism of action of each vaccine adjuvant may have different effects on the course of autoimmune conditions resulting from vaccination Read More Aluminum in Childhood Vaccines Is Unsafe Neil Z. Miller. Journal of American Physicians and Surgeons, Winter 2016. Aluminum in vaccines is highly neurotoxic and exposure levels given to infants have dramatically increased. Read More Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil Inbar R, Weiss R, Tomljenovic L, Arango M-T, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y. Immunologic Research. 2017;65(1):136-149. Israeli, Canadian and Colombian scientists show that the Gardasil vaccine triggers brain inflammation and autoimmunity in mice. Read More Combined subchronic toxicity of aluminum (III), titanium (IV) and silicon (IV) oxide nanoparticles and its alleviation with a complex of bioprotectors IA Minigalieva, BA Katsnelson, LI Privalova, et al. International Journal of Molecular Sciences, March 2018;19(3):837. Aluminum nanoparticles are toxic on their own and in combination with other metal nanoparticles. Read More Synergism in aluminum and mercury neurotoxicity Peter N Alexandrov,1 Aileen I Pogue,2 and Walter J Lukiw Aluminum and mercury sulfates may contribute to neurodegeneration and progressive age-related functional decline such as Alzheimer’s disease. Read More Reconsideration of the immunotherapeutic pediatric safe dose levels of aluminum James Lyons-Weiler 1, Robert Ricketson 2 The levels of aluminum present in individual vaccines and in the modern vaccine schedule as a whole are problematically high. Read More Aluminium in brain tissue in multiple sclerosis Matthew Mold,1 Agata Chmielecka,2 Maria Raquel Ramirez Rodriguez,1 Femia Thom,2 Caroline Linhart,3 Andrew King,4 and Christopher Exley1,* The first-ever measurements of aluminum in the brain tissue of donors with multiple sclerosis detected pathologically significant levels of aluminum in every single individual. Read More Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: a possible role of fluoride and aluminum Strunecka A, Blaylock RL, Patocka J, Strunecky O. Surgical Neurology International. 2018;9:74. Fluoride and aluminum, alone or in combination, can produce the condition of “immunoexcitotoxicity” that leads to the pathological changes seen in autism. Read More Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action Emma Shardlow, Matthew Mold & Christopher Exley Aluminum adjuvants in vaccines produce toxic effects ranging from benign to fatal, depending on the physicochemical properties of the adjuvant and the physiological response of the vaccine recipient. Read More Aluminium toxicosis: a review of toxic actions and effects Ikechukwu Onyebuchi Igbokwe, Ephraim Igwenagu, Nanacha Afifi Igbokwe. Interdiscip Toxicol. 2019; Vol. 12(2): 45–70. doi: 10.2478/intox-2019-0007 With the preliminary literature search starting in 2013 and looking backwards in time, research publications revealed a myriad of toxic actions of Aluminum causing pathological conditions. Read More Acute exposure and chronic retention of aluminum in three vaccine schedules and effects of genetic and environmental variation Journal of Trace Elements in Medicine and Biology Among the three schedules presented here, the CDC schedule exceeds the recommended dose limit for an infant (inferred from FDA adult “safe” levels) as a result of the simultaneous administration of multiple ACVs and insufficient spacing of ACVs. Read More Imaging of aluminium and amyloid β in neurodegenerative disease Christopher Exley∗ and Matthew J. Mold We suggest that complementary aluminium-specific fluorescence microscopy may reveal important information about the putative toxicity of aluminium in neurodegenerative and neurodevelopmental disorders. Read More Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months Academic Pediatrics In a large observational study, a positive association was found between vaccine-related aluminum exposure and persistent asthma. While recognizing the small effect sizes identified and the potential for residual confounding, additional investigation of this hypothesis appears warranted. Read More Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link? IOS Press The hypothesis that Al significantly contributes to AD is built upon very solid experimental evidence and should not be dismissed. Immediate steps should be taken to lessen human exposure to Al, which may be the single most aggravating and avoidable factor related to AD. Read More Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice Springer The findings suggest a possible role for the aluminum adjuvant in some neurological features associated with GWI and possibly an additional role for the combination of adjuvants. Read More Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes Journal of Inorganic Biochemistry Repetitive administration of aluminium to neonatal mice in amounts comparable to those to children receive via routine vaccinations significantly increases anxiety and reduces exploratory behaviour and locomotor activities. The neurodisruptive effects of aluminium are long-lasting and persist for 6 months following injection. Read More STUDY: CDC VACCINE SCHEDULE LIKELY INDUCES ALUMINUM TOXICITY IN NEWBORNS Jefferey Jaxen A new study published in the Journal of Trace Elements in Medicine and Biology concluded the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine schedule was 15.9 times over the recommended safe level of aluminum when researchers adjusted for body weight. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results BACK TO INGREDIENTS Polysorbate 80 Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner Holder MK, Peters NV, Whylings J, Fields CT, Gewirtz AT, Chassaing B, de Vries GJ. Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner. Sci Rep. 2019 Jan 17;9(1):172. doi: 10.1038/s41598-018-36890-3. PMID: 30655577; PMCID: PMC6336787. Dietary emulsifiers carboxylmethylcellulose (CMC) and polysorbate 80 (P80) alter the composition of the intestinal microbiota and induce chronic low-grade inflammation, ultimately leading to metabolic dysregulations in mice. Importantly, emulsifier treatment altered anxiety-like behaviors in males and reduced social behavior in females. It also changed expression of neuropeptides implicated in the modulation of feeding as well as social and anxiety-related behaviors. Read More Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes Tatsuishi T, Oyama Y, Iwase K, Yamaguchi JY, Kobayashi M, Nishimura Y, Kanada A, Hirama S. Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes. Toxicology. 2005 Feb 1;207(1):7-14. doi: 10.1016/j.tox.2004.07.020. PMID: 15590117. Polysorbate 80 at clinically-relevant concentrations increases the cytotoxicity of hydrogen peroxide under the in vitro condition. Result suggests that polysorbate 80 may increase the susceptibility of cells to oxidative stress. Read More Dual effects of Tween 80 on protein stability Wang W, Wang YJ, Wang DQ. Dual effects of Tween 80 on protein stability. Int J Pharm. 2008 Jan 22;347(1-2):31-8. doi: 10.1016/j.ijpharm.2007.06.042. Epub 2007 Jul 3. PMID: 17692480. Tween 80 increased the rate of oxidation in general but also altered the temperature-dependency of IL-2 mutein oxidation. Read More Polysorbate 80-induced leaky gut impairs skeletal muscle metabolism in mice Nishimura S, Aoi W, Kodani H, Kobayashi Y, Wada S, Kuwahata M, Higashi A. results suggest that daily PS80 intake induces intestinal permeability, leading to glucose intolerance and mitochondrial dysfunction in the skeletal muscle. Read More Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma Viennois E, Chassaing B. Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma. Int J Mol Sci. 2021 Mar 5;22(5):2602. doi: 10.3390/ijms22052602. PMID: 33807577; PMCID: PMC7961571. Overall, our findings further support the hypothesis that emulsifier consumption may be a new modifiable risk factor for colorectal cancer (CRC) and that alterations in host-microbiota interactions can favor gastrointestinal carcinogenesis in individuals with a genetical predisposition to such disorders. Read More Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier Zhao YM, Xia AX, Wei YH, Ruan YP, Li FZ. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier]. Yao Xue Xue Bao. 2010 Oct;45(10):1312-6. Chinese. PMID: 21348312. polysorbate-80 modified neurotoxin nanoparticles can transport across the BBB Read More Dietary emulsifier polysorbate-80-induced small-intestinal vulnerability to indomethacin-induced lesions via dysbiosis Furuhashi H, Higashiyama M, Okada Y, Kurihara C, Wada A, Horiuchi K, Hanawa Y, Mizoguchi A, Nishii S, Inaba K, Sugihara N, Watanabe C, Komoto S, Tomita K, Miura S, Hokari R. Polysorbate-80 enhances the vulnerability of the small intestine to indomethacin-induced injury by inducing ileal dysbiosis. Direct enhancement of the motility of specific flagellated microbiota by P80 might be related to dysbiosis and intestinal injury. Read More Flow-cytometric analysis on adverse effects of polysorbate 80 in rat thymocytes Hirama S, Tatsuishi T, Iwase K, Nakao H, Umebayashi C, Nishizaki Y, Kobayashi M, Ishida S, Okano Y, Oyama Y. Polysorbate 80 increases membrane permeability and decreased glutathione content. Read More Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res. 2017 Jan 1;77(1):27-40. doi: 10.1158/0008-5472.CAN-16-1359. Epub 2016 Nov 7. PMID: 27821485; PMCID: PMC5214513. Here, we demonstrate in a preclinical model of colitis-induced colorectal cancer that regular consumption of dietary emulsifiers, carboxymethylcellulose or polysorbate-80, exacerbated tumor development. Enhanced tumor development was associated with an altered microbiota metagenome characterized by elevated levels of lipopolysaccharide and flagellin Read More Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles Ren T, Xu N, Cao C, Yuan W, Yu X, Chen J, Ren J. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles. J Biomater Sci Polym Ed. 2009;20(10):1369-80. doi: 10.1163/092050609X12457418779185. PMID: 19622277. The prepared nanoparticles were spherical with homogeneous distribution. Drug concentration in mice brain was greatly enhanced, which indicated that the coated nanoparticles could get across the BBB Read More Macromolecules in polysorbate 80 for injection: an important cause of anaphylactoid reactions Li Y, Duan J, Xia H, Li Y, Shu B, Duan W. macromolecular impurities may cause strong anaphylactoid reactions, passive cutaneous anaphylactoid (PCA) reactions, pulmonary capillary permeability, vasodilation, and severe hemolysis Read More Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. relatively low concentrations of two commonly used emulsifiers, namely carboxymethylcellulose and polysorbate-80, induced low-grade inflammation and obesity/metabolic syndrome in wild-type hosts and promoted robust colitis in mice predisposed to this disorder. Emulsifier-induced metabolic syndrome was associated with microbiota encroachment, altered species composition and increased pro-inflammatory potential. Read More

Why I Won't Vax Home I Don't Trust Big Pharma Conflicts of Interest No Liability The Vaccine Inserts Inadequate Safety Testing Ingredients The Risks Outweigh The Benefit Unvaxxed are Healthier Decline in Illness Prior to Vaccines Vaccine Failure & Shedding Autism Vaccines Dont Cause Autism Vaccines Do Cause Autism Search Results Return to Ingredients Aluminum Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. 2011 Nov;105(11):1489-99. doi: 10.1016/j.jinorgbio.2011.08.008. Epub 2011 Aug 23. PMID: 22099159. Our results show that: (i) children from countries with the highest ASD prevalence appear to have the highest exposure to Al from vaccines; (ii) the increase in exposure to Al adjuvants significantly correlates with the increase in ASD prevalence in the United States observed over the last two decades Read More Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure Seneff, S.; Davidson, R.M.; Liu, J. Empirical Data Confirm Autism Symptoms Related to Aluminum and Acetaminophen Exposure. Entropy 2012, 14, 2227-2253. https://doi.org/10.3390/e14112227 In this paper, we have presented some analyses of the VAERS database which strongly suggest that the aluminum in vaccines is toxic to vulnerable children. While we have not shown that aluminum is directly causative in autism, the compelling evidence available from the literature on the toxicity of aluminum, combined with the evidence we present for severe adverse reactions occurring much more frequently following administration of aluminum-containing vaccines as compared to non-aluminum-containing vaccines, suggests that neuronal damage due to aluminum penetration into the nervous system may be a significant factor in autism. Read More Experimental Epilepsy in the Monkey Following Multiple Intracerebral Injections of Alumina Cream Joseph G. Chusid, Lenore M. Kopeloff, Ph.D. and Nicholas Kopeloff, Ph.D. The Bulletin, 1953. Aluminum caused tics and grand mal seizures in monkeys. Read More Macrophagic myofasciitis lesions assess long-term persistence of vaccine derived aluminum hydroxide in muscle R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P.A. Dreyfus. Brain, 2001, 124, 1821-1831. French scientists tie aluminum adjuvant in vaccine to macrophagic myofasciitis. Read More Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction Maryline Couette, Marie-Françoise Boisse, Patrick Maison, Pierre Brugieres, Pierre Cesaro, Xavier Chevalier, Romain K. Gherardi, Anne-Catherine Bachoud-Levi, François-Jérôme Authier. Journal of Inorganic Biochemistry, 2009. French scientists report aluminum from vaccines causes chronic cognitive dysfunction. Read More Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity Shaw C, Tomljenovic L. Immunologic Research. 2013;56:304–316. Canadian researchers: aluminum in vaccines can cause both autoimmunity and neurological damage. Read More Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Journal of Autoimmunity. 2013;47:1-16. Israeli and Italian researchers demonstrate that exposure to aluminum in vaccines can lead to autoimmune and brain dysfunction. Read More Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods. Fanni D, et al. World Journal of Pediatrics, 2014 May; 10(2):101-7. Newborns have been overexposed to aluminum. Read More Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity Tanveer Singh and Rajesh Kumar Goel. NeuroToxicology, 49 (2015) 1–7. Chronic aluminium administration resulted in significant motor incoordination and memory deficits, which were also endorsed biochemically as there was increased oxidative stress as well as elevated aluminium levels in the brain. Read More Assessment of hair aluminum, lead, and mercury in a sample of autistic Egyptian children: Environmental risk factors of heavy metals in autism El Baz Mohamed F, Zaky EA, Bassuoni EI-Sayed A, et al. Behavioural Neurology. 2015, Article ID 545674. Autistic children accumulate metals at a much higher level than children who do not have a diagnosis of autism. Read More On vaccine’s adjuvants and autoimmunity: Current evidence and future perspectives Pellegrino P, Clementi E, Radice S. Autoimmunity Reviews. 2015;14(10):880-888. The specific mechanism of action of each vaccine adjuvant may have different effects on the course of autoimmune conditions resulting from vaccination Read More Aluminum in Childhood Vaccines Is Unsafe Neil Z. Miller. Journal of American Physicians and Surgeons, Winter 2016. Aluminum in vaccines is highly neurotoxic and exposure levels given to infants have dramatically increased. Read More Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil Inbar R, Weiss R, Tomljenovic L, Arango M-T, Deri Y, Shaw CA, Chapman J, Blank M, Shoenfeld Y. Immunologic Research. 2017;65(1):136-149. Israeli, Canadian and Colombian scientists show that the Gardasil vaccine triggers brain inflammation and autoimmunity in mice. Read More Combined subchronic toxicity of aluminum (III), titanium (IV) and silicon (IV) oxide nanoparticles and its alleviation with a complex of bioprotectors IA Minigalieva, BA Katsnelson, LI Privalova, et al. International Journal of Molecular Sciences, March 2018;19(3):837. Aluminum nanoparticles are toxic on their own and in combination with other metal nanoparticles. Read More Synergism in aluminum and mercury neurotoxicity Peter N Alexandrov,1 Aileen I Pogue,2 and Walter J Lukiw Aluminum and mercury sulfates may contribute to neurodegeneration and progressive age-related functional decline such as Alzheimer’s disease. Read More Reconsideration of the immunotherapeutic pediatric safe dose levels of aluminum James Lyons-Weiler 1, Robert Ricketson 2 The levels of aluminum present in individual vaccines and in the modern vaccine schedule as a whole are problematically high. Read More Aluminium in brain tissue in multiple sclerosis Matthew Mold,1 Agata Chmielecka,2 Maria Raquel Ramirez Rodriguez,1 Femia Thom,2 Caroline Linhart,3 Andrew King,4 and Christopher Exley1,* The first-ever measurements of aluminum in the brain tissue of donors with multiple sclerosis detected pathologically significant levels of aluminum in every single individual. Read More Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: a possible role of fluoride and aluminum Strunecka A, Blaylock RL, Patocka J, Strunecky O. Surgical Neurology International. 2018;9:74. Fluoride and aluminum, alone or in combination, can produce the condition of “immunoexcitotoxicity” that leads to the pathological changes seen in autism. Read More Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action Emma Shardlow, Matthew Mold & Christopher Exley Aluminum adjuvants in vaccines produce toxic effects ranging from benign to fatal, depending on the physicochemical properties of the adjuvant and the physiological response of the vaccine recipient. Read More Aluminium toxicosis: a review of toxic actions and effects Ikechukwu Onyebuchi Igbokwe, Ephraim Igwenagu, Nanacha Afifi Igbokwe. Interdiscip Toxicol. 2019; Vol. 12(2): 45–70. doi: 10.2478/intox-2019-0007 With the preliminary literature search starting in 2013 and looking backwards in time, research publications revealed a myriad of toxic actions of Aluminum causing pathological conditions. Read More Acute exposure and chronic retention of aluminum in three vaccine schedules and effects of genetic and environmental variation Journal of Trace Elements in Medicine and Biology Among the three schedules presented here, the CDC schedule exceeds the recommended dose limit for an infant (inferred from FDA adult “safe” levels) as a result of the simultaneous administration of multiple ACVs and insufficient spacing of ACVs. Read More Imaging of aluminium and amyloid β in neurodegenerative disease Christopher Exley∗ and Matthew J. Mold We suggest that complementary aluminium-specific fluorescence microscopy may reveal important information about the putative toxicity of aluminium in neurodegenerative and neurodevelopmental disorders. Read More Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months Academic Pediatrics In a large observational study, a positive association was found between vaccine-related aluminum exposure and persistent asthma. While recognizing the small effect sizes identified and the potential for residual confounding, additional investigation of this hypothesis appears warranted. Read More Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link? IOS Press The hypothesis that Al significantly contributes to AD is built upon very solid experimental evidence and should not be dismissed. Immediate steps should be taken to lessen human exposure to Al, which may be the single most aggravating and avoidable factor related to AD. Read More Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice Springer The findings suggest a possible role for the aluminum adjuvant in some neurological features associated with GWI and possibly an additional role for the combination of adjuvants. Read More Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes Journal of Inorganic Biochemistry Repetitive administration of aluminium to neonatal mice in amounts comparable to those to children receive via routine vaccinations significantly increases anxiety and reduces exploratory behaviour and locomotor activities. The neurodisruptive effects of aluminium are long-lasting and persist for 6 months following injection. Read More STUDY: CDC VACCINE SCHEDULE LIKELY INDUCES ALUMINUM TOXICITY IN NEWBORNS Jefferey Jaxen A new study published in the Journal of Trace Elements in Medicine and Biology concluded the U.S. Centers for Disease Control and Prevention’s (CDC) vaccine schedule was 15.9 times over the recommended safe level of aluminum when researchers adjusted for body weight. Read More